San Francisco, CA | 14 January 2026
Dr. Novack met with numerous biomedical companies during the JPMorgan Biomedical Conference in San Francisco. Dr. Novack provided consultation to clients of PharmaLogic on a wide range of development issues. This includes the potential impact of U.S. Food & Drug Administration policy statements on their investigational ophthalmic therapeutics.
The energy in Union Square approached that of pre-COVID pandemic years. Many attendees were optimistic about the promise of novel therapies, and the potential investment by venture capital and the large strategic firms.
Dr. Novack shown about to board the Larkspur (Marin County) ferry to San Francisco